SOURCE: The Radiant Creations Group, Inc.
PALM BEACH GARDENS, FL--(Marketwired - February 07, 2014) - The Radiant Creations Group, Inc. ("Radiant") (OTCQB: RCGP), developer of unique, proprietary scientific technologies for cosmetic and over-the-counter personal enhancement products and devices, is pleased to announce the Company has achieved and exceeded the funding goal established by management and reflected in the Company's Executive Summary, a copy of which can be obtained upon request.
On February 4, 2014, the Company executed an agreement and received $250,000 that completes its initial projected funding requirements. The agreement includes a "right-of-first-refusal" provision to provide additional funds for the purpose of launching new products and expansion of our specialized marketing platform.
Since the change in control on June 27, 2013, Management had projected a capital funding demand needed to sustain the company and launch its initial product "Revivasol" Anti-Aging & Revitalizing Cream of approximately $150,000 per month for approximately eight months, through January, 2014. Following the launch of our specialized marketing program on November, 19, 2013, the Company has recorded accrual based gross revenues of $557,000 on shipments of 8,300 units.
Gary D. Alexander, CFO of Radiant stated "the Company releases this information to the investing public to further define the financial stability of the Company and to detail the impressive revenue growth generated by our specialized marketing platform. The funding provided allows the Company to accelerate its anticipated launch of its second product Revivasol's -- acne solution from the third quarter 2014, as originally projected, to the second quarter, 2014 thereby greatly enhancing the Company's financial projections through fiscal year-end February 28, 2015."
About The Radiant Creations Group, Inc. (RCGP)
Radiant Creations has achieved exciting breakthroughs creating remarkable products in skin protection and hydration, anti-aging, liver health and weight balance by combining DNA technologies developed in the Western World and naturally acting traditional Chinese medicine ingredients believed never before used in western culture by any bioscience company.
Among these exciting discoveries is a new and superior mechanism of defense against skin deterioration and damage caused by sun exposure to ultraviolet (UV) light using the nucleotides, four "code molecules" extracted from DNA. This revolutionary mechanism also has great significance and value in many other cosmetic and non-cosmetic applications requiring UV protection, and is among Radiant Creation's licensed patented intellectual property. The technology will be implemented across numerous innovative product lines.
Cautionary Statement Concerning forward-Looking Statements:
This press release contains forward-looking statements that can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.
Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.